We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Renalytix plc (RENX) ORD GBP0.0025

Sell:7.50p Buy:8.00p 0 Change: No change
Market closed Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:7.50p
Buy:8.00p
Change: No change
Market closed Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:7.50p
Buy:8.00p
Change: No change
Market closed Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. The Company’s lead product, KidneyIntelX platform, is designed to scale across kidney disease conditions beyond diabetic kidney disease. It is evaluating a range of indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations and COVID-related kidney disease. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Contact details

Address:
Finsgate, 5-7 Cranwood Street
LONDON
EC1V 9EE
United Kingdom
Telephone:
+44 (029) 20710570
Website:
https://renalytix.com/

Important dates

Future events
There are no future events available.
Past events
Annual report 21 November 2024 21/11/24
Quarterly results 20 November 2024 20/11/24
General meeting 31 October 2024 31/10/24
General meeting 01 October 2024 01/10/24
Final results 30 September 2024 30/09/24
Quarter 3 results 15 May 2024 15/05/24
General meeting 22 April 2024 22/04/24
Interim results 15 February 2024 15/02/24
AGM 15 December 2023 15/12/23

General stock information

EPIC:
RENX
ISIN:
GB00BYWL4Y04
Market cap:
£25.86 million
Shares in issue:
333.64 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.